Skip to main content

Peer Review reports

From: Effectiveness of bevacizumab in the treatment of metastatic colorectal cancer: a systematic review and meta-analysis

Original Submission
9 May 2023 Submitted Original manuscript
5 Sep 2023 Reviewed Reviewer Report
9 Oct 2023 Reviewed Reviewer Report - Tsunehiko Maruyama
12 Nov 2023 Reviewed Reviewer Report
6 Dec 2023 Author responded Author comments - Cheng-Jiang Liu
Resubmission - Version 2
6 Dec 2023 Submitted Manuscript version 2
8 Dec 2023 Author responded Author comments - Cheng-Jiang Liu
Resubmission - Version 3
8 Dec 2023 Submitted Manuscript version 3
18 Dec 2023 Reviewed Reviewer Report
23 Dec 2023 Reviewed Reviewer Report - Tsunehiko Maruyama
8 Jan 2024 Author responded Author comments - Cheng-Jiang Liu
Resubmission - Version 4
8 Jan 2024 Submitted Manuscript version 4
11 Jan 2024 Author responded Author comments - Cheng-Jiang Liu
Resubmission - Version 5
11 Jan 2024 Submitted Manuscript version 5
Publishing
14 Jan 2024 Editorially accepted
1 Feb 2024 Article published 10.1186/s12876-024-03134-w

You can find further information about peer review here.

Back to article page